Filing Details
- Accession Number:
- 0001267602-16-000161
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-16 16:25:39
- Reporting Period:
- 2016-09-15
- Filing Date:
- 2016-09-16
- Accepted Time:
- 2016-09-16 16:25:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1267602 | Alimera Sciences Inc | ALIM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1374256 | Jr S Richard Eiswirth | 6120 Windward Parkway, Suite 290 Alpharetta GA 30005 | President And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-09-15 | 51,471 | $1.33 | 86,445 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-09-15 | 51,471 | $1.51 | 34,974 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2016-09-15 | 51,471 | $0.00 | 51,471 | $1.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-10-12 | No | 4 | M | Direct |
Footnotes
- This sale occurred in accordance with the Reporting Person's 10b5-1 plan adopted on August 12, 2015.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.49 to $1.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- Became exercisable with respect to 1/4 of the shares of stock which are subject to this option on 11/22/07 (the "Initial Vesting Date") and with respect to the remainder of the shares in equal increments quarterly over three years beginning on the date three (3) months from the Initial Vesting Date.
Billionaire Hedge Funds
